Option Care Health, Inc.
OPCHHealthcareNASDAQMedical Care Facilities · Last scanned Oct 26, 2026
Scan Results
Daily timeframeOption Care Health, Inc. offers home and alternate site infusion services in the United States. The $4.68B market capitalization puts OPCH squarely in mid-cap range for its industry. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Market Cap
$4.68B
Beta
0.58
P/E (TTM)
23.65
P/E (Fwd)
14.99
EPS (TTM)
$1.32
EPS (Fwd)
$2.08
ROE
16.0%
ROA
6.2%
Cash
$196.8M
Total Debt
$1.27B
Free CF
$256.1M
52W Change
12.1%
Annual Financials
Cash vs Debt
Where OPCH stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, OPCH finished 29.72% above its 150-day moving average ($24.06) and 18.26% above its 200-day moving average ($26.39). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is OPCH overbought or oversold?
At the October 20, 2026 close, OPCH's RSI(14) was 96.3, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, OPCH has $196.8M in cash with $1.27B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $256.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 16.0% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 6.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $3.44B (2021) to $5.65B (2025), reflecting a 64% increase over the period.
OPCH's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Option Care Health, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Option Care Health, Inc. and its sector.